Reuters logo
BRIEF-Neurovive signs collaboration agreement with Karolinska Institutet
January 10, 2017 / 7:36 AM / 10 months ago

BRIEF-Neurovive signs collaboration agreement with Karolinska Institutet

Jan 10 (Reuters) - Neurovive Pharmaceutical AB

* Neurovive signs collaboration agreement with Karolinska Institutet

* Says under the collaboration agreement, the team led by Prof. Hakan Westerblad at Karolinska Institutet will study Neurovive’s cyclophilin inhibitor compound NV556 and its effects in experimental models of mitochondrial myopathy Source text for Eikon: Further company coverage: (Stockholm Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below